Weight loss injections have become an important treatment option for people struggling with obesity and weight-related health problems. In Pakistan, patients often ask about two medicines: semaglutide and tirzepatide.
A common question is: Which is better for weight loss, semaglutide or tirzepatide?
Both medicines can help with weight management, reduce appetite, and improve blood sugar control. However, clinical research has found differences between them. A large head-to-head trial published in the New England Journal of Medicine compared the two medicines in adults with obesity who did not have type 2 diabetes. At 72 weeks, average weight reduction was 20.2% with tirzepatide compared with 13.7% with semaglutide.
This does not mean that one medicine is suitable for every patient. The right treatment depends on individual health, medical history, weight, diabetes status, other medicines, and possible side effects.
Semaglutide is a medicine that acts on the GLP-1 pathway. It can reduce hunger, increase feelings of fullness, and help patients eat less.
Tirzepatide works differently because it acts on both GIP and GLP-1 pathways. These effects can help regulate appetite, food intake, and blood sugar.
Both medicines are generally used as part of a broader weight management plan rather than as a replacement for healthy eating and physical activity.
For patients looking for Weight Loss Treatment in Islamabad, a medical assessment is important before starting any prescription weight loss medicine.
The strongest direct comparison comes from the SURMOUNT-5 trial. The study included 751 adults with obesity but without type 2 diabetes. Participants received weekly injections of either tirzepatide or semaglutide for 72 weeks.
The results showed:
These results show that tirzepatide produced greater average weight loss in this particular study population. However, individual results can be different.
Patients should not select or change medication only because one medicine produced greater average weight loss in a clinical trial.
Blood sugar control is another important reason these medicines may be prescribed.
Semaglutide and tirzepatide can both help improve blood glucose levels. Tirzepatide has also shown strong effects on blood sugar control in clinical research.
For people with obesity and diabetes, the treatment decision may therefore involve more than weight loss. Doctors may consider blood sugar levels, current diabetes medicines, kidney and liver health, and the risk of low blood sugar.
Patients taking insulin or certain other diabetes medicines may need careful monitoring because the combination can increase the risk of hypoglycemia.
This is why Gastroenterology Services in Islamabad can include broader assessment of digestive, metabolic, and liver health when appropriate.
Both semaglutide and tirzepatide can cause digestive side effects.
Common side effects may include:
In the SURMOUNT-5 trial, gastrointestinal side effects were common with both medicines and were mostly mild to moderate. They occurred mainly during dose escalation.
The medicine and dose may need to be adjusted depending on how a patient responds.
Patients should also tell their doctor about existing digestive problems, other medicines, and previous reactions to weight loss treatment.
No. Weight loss injections are only one part of a complete treatment plan.
The Islamabad Gastroenterology Associates approach to weight management also emphasizes diet, exercise, behavior, and digestive health. Their existing patient guidance notes that injections can support weight loss but do not replace healthy eating habits or physical activity.
A balanced plan may include:
This approach can help patients work toward sustainable weight management rather than focusing only on short-term weight loss.
Some patients prefer tablets because they do not want injections. Oral semaglutide is available for certain medical indications, but the appropriate medicine and formulation depend on the patient’s condition.
A doctor should assess whether oral or injectable treatment is appropriate rather than assuming that one option will work for everyone.
If weight loss has been difficult despite diet and exercise, discussing your options with a qualified specialist can help identify an appropriate treatment plan.
The available evidence shows that tirzepatide produced greater average weight loss than semaglutide in the 72-week SURMOUNT-5 head-to-head trial.
However, greater average weight loss does not automatically mean that tirzepatide is the right medicine for every patient.
Your doctor may consider:
For patients seeking a Best Gastroenterologist in Islamabad, Prof. Muzaffar Latif Gill is a gastroenterologist and hepatologist whose practice includes digestive and liver disease care. His website provides information about his clinical expertise and consultation services.
If you are considering semaglutide, tirzepatide, or another weight management medicine, do not start treatment without appropriate medical advice.
A consultation can help determine whether weight loss medication is suitable for you and whether additional evaluation is needed.
You can Book an Online Consultation with Islamabad Gastroenterology Associates for personalized medical guidance. The clinic lists consultation services and provides appointments for patients seeking evaluation and treatment.
In a 72-week head-to-head trial, tirzepatide produced greater average weight loss than semaglutide. Individual results can vary.
Yes. Semaglutide can help reduce appetite and body weight when prescribed appropriately as part of a comprehensive weight management plan.
Nausea, vomiting, abdominal discomfort, diarrhea, constipation, and reduced appetite can occur with these medicines.
These medicines may be used in appropriate patients with diabetes, but treatment should be selected and monitored by a doctor.
No. A healthy diet, physical activity, and sustainable lifestyle habits remain important parts of weight management.
No. These are prescription medicines and should be used under appropriate medical supervision.
Patients can consult a qualified specialist for assessment and personalized treatment planning. Islamabad Gastroenterology Associates provides consultation services in Islamabad.
